Orthopaedic Devices Global Market – Forecast To 2027

Publishing Date : January, 2021
Report Code : HCMD 0108
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

 

Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of orthopaedic device. As a result of rapid advances, there is great expansion in the potential therapeutic application for musculoskeletal injuries, deformities and diseases.

Orthopaedic devices are used to repair, reconstruct, and replacement of various bones and joints due fractures, injuries and other birth bone defects. The orthopaedic devices global market is expected to reach $53,607.2 million by 2027 growing at a high single digit CAGR. The market is primarily driven by the increase in incidence and prevalence of musculoskeletal diseases such as osteoarthritis, osteoporosis, spinal degenerative diseases, spondylitis, lower back pain, herniated spinal discs, and injuries due to trauma and sports activities, increase in the aging population, technological advancement, acquisitions and factors such as product recall, complications associated with implanted devices, lack of skilled and trained professionals to carry out minimally invasive surgery, high cost of the implant, surgery and also stringent regulatory policies for the product approval due to classification of the orthopaedic devices as class II and III devices are hindering the growth of the market.

Orthopaedic devices global market is segmented based on products, surgery type, end-users and geography. The products are segmented into knee, hip, extremities, spine, craniomaxillofacial, trauma, sports medicine, and orthobiologics.

Among products, the spine segment accounted the largest share in 2020 due to technological advancements in the implants, surgery type and increase in the aged population coupled with rise in number of trauma and sports injuries. The extremities segment anticipated as the fastest growing segment and expected to grow at a CAGR of high single digit CAGR from 2020 to 2027 due to increase in the road accident coupled with sports injuries and rise in the geriatric population.

The extremities by product type are segmented into upper and lower extremities. Among extremities, the upper extremities accounted for the highest revenue in 2020 and the lower extremities segment is the fastest growing segment and is projected to grow at a high single digit CAGR from 2020 to 2027 as the lower extremities consisting of foot, limb, and ankle are more susceptible to injury and fractures in as a result of trauma and sports activities. The upper extremity products are further segmented into shoulder and other upper extremities. Under upper extremities, the shoulder division accounted for the largest revenue share of the global upper extremities devices revenue in 2020 and is expected to grow at a double digit CAGR of from 2020 to 2027 owing to increased incidence of shoulder dislocation and pain associated as a result of rise in incidence of musculoskeletal diseases, occupational, sports and trauma injuries.

The spine segment by product type is segmented into fusion and non-fusion devices. Among the spine device market, the fusion device contributed for the largest revenue share of in 2020 and the non-fusion device division is expected to grow at a double digit CAGR from 2020 to 2027. As a result of rising awareness and better efficiency of spinal stabilization and retention of spinal movements by non-fusion devices as compared to the fusion-devices. Further the fusion device market is categorized into cervical devices, thoracolumbar devices and interbody devices. Among the fusion devices, thoracolumbar devices accounted for the largest revenue in 2020 and the interbody devices are expected to grow at a high single digit CAGR from 2020 to 2027 owing to rapid acceptance of spinal interbody arthrodesis and higher efficiency of reconstruction stability. The non-fusion segment is further classified into artificial disc, dynamic stabilization devices, and annulus repair devices. Among non-fusion devices, the dynamic stabilization device accounted for the largest revenue in 2020 and the artificial discs segment is expected to grow at a double digit CAGR from 2020 to 2027 as the artificial discs aid in the replacement of degenerated discs, movement retention and is the most preferred implant to overcome herniated disc and lower back pain.

The orthobiologics segment is further divided into synthetic graft, demineralized bone matrix, machined bone allograft, and others. Among orthobiologics, the machined bone allografts contributed for the highest revenue in 2020 and the demineralized bone matrix is expected to grow at a mid single digit CAGR from 2020 to 2027 owing to improved osteoconductive and osteoinductivity properties as compared to other grafts.

The global orthopaedic market by surgery type is segmented into open, minimally invasive and robotic-assisted surgery. Among surgery type, the open surgeries accounted for the highest revenue in 2020 and the robotic assisted surgery is anticipated to grow at a high teen CAGR from 2020 to 2027 due to technological advancements in robotics assisted surgery, favourable reimbursement scenarios for robotic-assisted surgeries and precise and accurate placing of implants with minimal damage to the other tissues and bones.

The global orthopaedic devices market by end-user is segmented into hospitals, orthopaedic clinics and ambulatory surgical centers. Among end-users, the hospital segment contributed for the largest revenue in 2020 and the ambulatory surgical center segment is expected to grow at a high single digit CAGR from 2020 to 2027 as a result of adoption of minimally invasive surgeries, shifting of in-patient surgeries to out-patient surgeries owing to reduced hospital expenditure, favourable reimbursement for surgeries carried under ambulatory surgical centers and reduced hospital stays.

The global orthopaedic devices market by geography is segmented as North America (U.S. and others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India, and Others) and Rest of the World (Brazil, Rest of Latin America and Middle East & others). North America accounted for the highest market share followed by Europe in 2020. Favourable reimbursement coverage, adoption of advanced minimally invasive procedures and increase in incidence and prevalence of orthopaedic diseases coupled with rising number of trauma and sports injuries are driving orthopaedic devices market. However, Asian countries especially India and China are the fastest growing nations at CAGR of double digit from 2020 to 2027 with its growing awareness on minimally invasive techniques, a gradual increase in the healthcare expenditure and increase in the aging population and reduction in the cost of orthopaedic devices.

The orthopaedic devices market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the orthopaedic devices global market are Stryker Corporation (U.S.), Medtronic Plc (Ireland), Zimmer Biomet Holdings Inc. (U.S.), Johnson & Johnson (DePuy Synthes, U.S.), Smith & Nephew Plc (U.K.), NuVasive Inc (U.S.), Globus Medical Inc. (U.S.), Arthrex Inc. (U.S.), Colfax Corporation (DJO, LLC, U.S.), and B. Braun Melsungen AG (Germany).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • U.K.
  • France
  • Others
  • Asia-Pacific 
  • Japan
  • China
  • India
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East & Others

 

 

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     HIGH PREVALENCE AND INCIDENCE OF ORTHOPAEDIC DISORDERS AND AN INCREASE IN THE AGING POPULATION
        • 3.3.1.2     INCREASE IN ACCIDENTS AND SPORTS INJURIES
        • 3.3.1.3     INCREASING DEMAND FOR MINIMALLY INVASIVE SURGERIES
        • 3.3.1.4     TECHNOLOGICAL ADVANCEMENTS
        • 3.3.1.5     ACQUISITION AND COLLABORATIONS AS A PART OF THE GROWTH STRATEGY
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     PRODUCT RECALLS DUE TO MANUFACTURING ERRORS
        • 3.3.2.2     LACK OF SKILLED ORTHOPAEDIC SURGEON
        • 3.3.2.3     ADVERSE EVENTS AND COMPLICATIONS WITH THE IMPLANTATIONS OF ORTHOPAEDIC DEVICES
        • 3.3.2.4     HIGH COST OF ORTHOPAEDIC IMPLANTS AND SURGERY
        • 3.3.2.5     STRINGENT REGULATORY POLICIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 13485 MEDICAL DEVICES
        • 3.4.1.3     ISO /TS 16782: 2016 CLINICAL LABORATORY TESTING
        • 3.4.1.4     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     THE U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     JAPAN
      • 3.4.6     CHINA
      • 3.4.7     INDIA
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     INTRODUCTION
      • 3.5.2     3D PRINTING AND DEVELOPMENT OF PATIENT-SPECIFIC IMPLANTS
      • 3.5.3     IMPLANT MATERIALS AND COATINGS
      • 3.5.4     SMART IMPLANTS
      • 3.5.5     EVOLUTION IN THE ROBOTIC-ASSISTED SURGERY WITH SMALLER INCISION AND POST-OPERATIVE CARE REDUCTION
    • 3.6     IMPLANT MATERIALS AND COATINGS
      • 3.6.1     METALS
      • 3.6.2     CERAMICS AND BIOGLASS
      • 3.6.3     POLYMER
    • 3.7     PORTER’S FIVE FORCE ANALYSIS
      • 3.7.1     THREAT OF NEW ENTRANTS
      • 3.7.2     THREAT OF SUBSTITUTES
      • 3.7.3     RIVALRY AMONG EXISTING PLAYERS
      • 3.7.4     BARGAINING POWER OF SUPPLIERS
      • 3.7.5     BARGAINING POWER OF BUYERS
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     REIMBURSEMENT SCENARIO
    • 3.10     PATENT SCENARIO
    • 3.11     FUNDING SCENARIO
    • 3.12     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.12.1     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS
      • 3.12.2     KNEE GLOBAL MARKET SHARE ANALYSIS
      • 3.12.3     HIP GLOBAL MARKET SHARE ANALYSIS
      • 3.12.4     SPINE GLOBAL MARKET SHARE ANALYSIS
      • 3.12.5     TRAUMA GLOBAL MARKET SHARE ANALYSIS
      • 3.12.6     SPORTS MEDICINE GLOBAL MARKET SHARE ANALYSIS
      • 3.12.7     ORTHOBIOLOGICS GLOBAL MARKET SHARE ANALYSIS
      • 3.12.8     SHOULDER GLOBAL MARKET SHARE ANALYSIS
      • 3.12.9     FOOT & ANKLE GLOBAL MARKET SHARE ANALYSIS
    • 3.13     ORTHOPAEDIC DEVICES NUMBER OF PROCEDURES BY REGION
      • 3.13.1     KNEE ARTHROPLASTY PROCEDURAL VOLUME BY REGION
      • 3.13.2     HIP ARTHROPLASTY PROCEDURAL VOLUME BY REGION
      • 3.13.3     SPINE ARTHROPLASTY PROCEDURAL VOLUME BY REGION
      • 3.13.4     SHOULDER ARTHROPLASTY PROCEDURAL VOLUME BY REGION
    • 3.14     ORTHOPAEDIC DEVICES COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, MATERIAL, AND APPLICATION
  • 4     ORTHOPAEDIC DEVICES GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     KNEE
    • 4.3     HIP
    • 4.4     EXTREMITIES
      • 4.4.1     UPPER EXTREMITIES
        • 4.4.1.1     SHOULDER
        • 4.4.1.2     OTHER UPPER EXTREMITIES
      • 4.4.2     LOWER EXTREMITIES
    • 4.5     SPINE
      • 4.5.1     FUSION DEVICES
        • 4.5.1.1     CERVICAL DEVICES
        • 4.5.1.2     THORACOLUMBAR DEVICES
        • 4.5.1.3     INTERBODY DEVICES
      • 4.5.2     NON-FUSION
        • 4.5.2.1     ARTIFICIAL DISCS
        • 4.5.2.2     DYNAMIC STABILIZATION DEVICES
        • 4.5.2.3     ANNULUS REPAIR DEVICES
    • 4.6     CRANIOMAXILLOFACIAL
    • 4.7     TRAUMA
    • 4.8     SPORTS MEDICINE
    • 4.9     ORTHOBIOLOGICS
      • 4.9.1     SYNTHETICS
      • 4.9.2     DEMINERALIZED BONE MATRIX
      • 4.9.3     MACHINED BONE ALLOGRAFT
      • 4.9.4     OTHER ORTHOBIOLOGICS
  • 5     ORTHOPAEDIC GLOBAL MARKET, BY SURGERY TYPE
    • 5.1     INTRODUCTION
    • 5.2     OPEN SURGERY
    • 5.3     MINIMALLY INVASIVE SURGERY
    • 5.4     ROBOTIC ASSISTED SURGERY
  • 6     ORTHOPAEDIC DEVICES GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     ORTHOPAEDIC CLINICS
  • 7     REGIONAL ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     U.K.
      • 7.3.4     REST OF EUROPE
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     INDIA
      • 7.4.3     CHINA
      • 7.4.4     REST OF APAC
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     COMPETITIVE LANDSCAPE
    • 8.1     INTRODUCTION
    • 8.2     PRODUCT LAUNCH
    • 8.3     PRODUCT APPROVAL
    • 8.4     ACQUISITION
    • 8.5     AGREEMENTS
    • 8.6     OTHER DEVELOPMENTS
  • 9     MAJOR COMPANIES
    • 9.1     ARTHREX INC
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     B. BRAUN MELSUNGEN AG
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     COLFAX CORPORATION (DJO, LLC)
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     GLOBUS MEDICAL, INC.
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     JOHNSON & JOHNSON (DEPUY SYNTHES)
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     MEDTRONIC PUBLIC LIMITED COMPANY
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     NUVASIVE INC.
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     SMITH & NEPHEW PLC, PLC.
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     STRYKER CORPORATION
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     ZIMMER BIOMET HOLDINGS, INC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     ORTHOPAEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 2     AVERAGE SELLING PRICE (ASP) OF HIP, KNEE, SHOULDER AND SPINE IMPLANTS (2020) ($)
      • TABLE 3     ORTHOPAEDIC DEVICES FUNDINGS
      • TABLE 4     KNEE ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 5     TOTAL KNEE ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 6     UNICONDYLAR KNEE ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 7     REVISION KNEE ARTHROPLASTY ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 8     HIP ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 9     TOTAL HIP ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 10     PARTIAL HIP ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 11     HIP RESURFACING ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 12     REVISION HIP ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 13     SPINE ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 14     SHOULDER ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 15     PRIMARY TOTAL SHOULDER ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 16     REVERSE SHOULDER ARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 17     SHOULDER HEMIARTHROPLASTY PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 18     SHOULDER RESURFACING PROCEDURE, BY REGION, (2019-2027) (NO’S)
      • TABLE 19     ORTHOPAEDIC DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 20     KNEE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 21     HIP GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 22     EXTREMITIES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 23     EXTREMITIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 24     UPPER EXTREMITIES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 25     UPPER EXTREMITIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 26     SHOULDER GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 27     OTHER UPPER EXTREMITIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 28     LOWER EXTREMITIES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 29     SPINE GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 30     SPINE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 31     FUSION DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 32     FUSION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 33     CERVICAL DEVICES MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 34     THORACOLUMBAR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 35     INTERBODY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 36     NON-FUSION GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 37     NON-FUSION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 38     ARTIFICIAL DISCS MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 39     DYNAMIC STABILIZATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 40     ANNULUS REPAIR DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 41     CRANIOMAXILLOFACIAL GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 42     TRAUMA GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 43     SPORTS MEDICINE GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 44     ORTHOBIOLOGICS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 45     ORTHOBIOLOGICS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 46     SYNTHETICS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 47     DEMINERALIZED BONE MATRIX GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 48     MACHINED BONE ALLOGRAFT GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 49     OTHER ORTHOBIOLOGICS GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 50     ORTHPAEDIC DEVICES GLOBAL MARKET REVENUE, BY SURGERY TYPE, (2019-2027) ($MN)
      • TABLE 51     OPEN SURGERY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 52     MINIMALLY INVASIVE SURGERY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 53     ROBOTIC-ASSISTED SURGERY GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 54     GLOBAL ORTHOPAEDIC DEVICES MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 55     HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • TABLE 56     AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • TABLE 57     ORTHOPAEDIC CLINICS GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • TABLE 58     ORTHOPAEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2027) ($MN)
      • TABLE 59     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 60     NORTH AMERICA EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 61     NORTH AMERICA UPPER EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 62     NORTH AMERICA SPINE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 63     NORTH AMERICA FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 64     NORTH AMERICA NON-FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 65     NORTH AMERICA ORTHOBIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 66     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY SURGERY TYPE, (2019-2027) ($MN)
      • TABLE 67     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 68     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 69     EUROPE ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 70     EUROPE EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 71     EUROPE UPPER EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 72     EUROPE SPINE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 73     EUROPE FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 74     EUROPE NON-FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 75     EUROPE ORTHOBIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 76     EUROPE ORTHOPAEDIC DEVICES MARKET REVENUE, BY SURGERY TYPE, (2019-2027) ($MN)
      • TABLE 77     EUROPE ORTHOPAEDIC DEVICES MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 78     EUROPE ORTHOPAEDIC DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 79     ASIA-PACIFIC ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 80     ASIA-PACIFIC EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 81     ASIA-PACIFIC UPPER EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 82     ASIA-PACIFIC SPINE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 83     ASIA-PACIFIC FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 84     ASIA-PACIFIC NON-FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 85     ASIA-PACIFIC ORTHOBIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 86     APAC ORTHOPAEDIC DEVICES MARKET REVENUE, BY SURGERY TYPE, (2019-2027) ($MN)
      • TABLE 87     ASIA-PACIFIC ORTHOPAEDIC DEVICES MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 88     ASIA-PACIFIC ORTHOPAEDIC DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 89     REST OF THE WORLD ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, (2019-2027) ($MN)
      • TABLE 90     REST OF THE WORLD EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 91     REST OF THE WORLD UPPER EXTREMITIES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 92     REST OF THE WORLD SPINE MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 93     REST OF THE WORLD FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 94     REST OF THE WORLD NON-FUSION DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 95     REST OF THE WORLD ORTHOBIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2019-2027) ($MN)
      • TABLE 96     REST OF THE WORLD ORTHOPAEDIC DEVICES MARKET REVENUE, BY SURGERY TYPE, (2019-2027) ($MN)
      • TABLE 97     REST OF THE WORLD ORTHOPAEDIC DEVICES MARKET REVENUE, BY END-USERS (2019-2027) ($MN)
      • TABLE 98     REST OF THE WORLD ORTHOPAEDIC DEVICES MARKET REVENUE, BY COUNTRY, (2019-2027) ($MN)
      • TABLE 99     PRODUCT LAUNCH
      • TABLE 100     PRODUCT APPROVAL
      • TABLE 101     ACQUISITION
      • TABLE 102     AGREEMENTS
      • TABLE 103     OTHER DEVELOPMENTS
      • TABLE 104     B BRAUN MELSUNGEN: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
      • TABLE 105     B BRAUN MELSUNGEN: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
      • TABLE 106     B BRAUN MELSUNGEN: TOTAL REVENUE, BY GEOGRAPHY (2017-2019) ($MN)
      • TABLE 107     COLFAX CORPORATION (DJO, LLC): TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 108     COLFAX CORPORATION (DJO, LLC): TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 109     GLOBUS MEDICAL INC.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 110     GLOBUS MEDICAL INC.: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 111     GLOBUS MEDICAL, INC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 112     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2018 -2020) ($MN)
      • TABLE 113     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 114     JOHNSON & JOHNSON: MEDICAL DEVICE REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 115     JOHNSON & JOHNSON: ORTHOPAEDIC DEVICE REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 116     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 117     MEDTRONIC PLC: TOTAL REVENUE AND OPERATING EXPENSES (2019-2021) ($MN)
      • TABLE 118     MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
      • TABLE 119     MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 120     NUVASIVE INC.: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 121     NUVASIVE INC.: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 122     NUVASIVE, INC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 123     SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 124     SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 125     SMITH & NEPHEW PLC: ORTHOPAEDIC REVENUE, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 126     SMITH & NEPHEW PLC: SPORTS MEDICINE & ENT, BY SUB-SEGMENTS, (2018-2020) ($MN)
      • TABLE 127     SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 128     STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 129     STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 130     STRYKER CORPORATION: ORTHOPAEDICS, BY SUB-SEGMENT, (2018-2020) ($MN)
      • TABLE 131     STRYKER CORPORATION: NEUROTECHNOLOGY AND SPINE REVENUE, BY SUB-SEGMENT, (2018-2020) ($MN)
      • TABLE 132     STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
      • TABLE 133     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
      • TABLE 134     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY SEGMENTS, (2018-2020) ($MN)
      • TABLE 135     ZIMMER BIOMET HOLDINGS, INC: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)

      LIST OF FIGURES

      • FIGURE 1     ORTHOPAEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: ORTHOPAEDIC DEVICES GLOBAL MARKET
      • FIGURE 3     ORTHOPAEDIC DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     ORTHOPAEDIC DEVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     ORTHOPAEDIC DEVICES GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
      • FIGURE 6     ORTHOPAEDIC DEVICES GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     ORTHOPAEDIC DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     ORTHOPAEDIC DEVICES: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     ORTHOPAEDIC DEVICES GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2015–2020)
      • FIGURE 11     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 12     KNEE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 13     HIP GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 14     SPINE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 15     TRAUMA GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 16     SPORTS MEDICINE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 17     ORTHOBIOLOGICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 18     SHOULDER GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 19     FOOT & ANKLE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2020 (%)
      • FIGURE 20     KNEE ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 21     TOTAL KNEE ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 22     HIP ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 23     TOTAL HIP ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 24     SPINE ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 25     SHOULDER ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 26     PRIMARY TOTAL SHOULDER ARTHROPLASTY PROCEDURAL VOLUME, BY REGION (2020 V/S 2027) (NO’S)
      • FIGURE 27     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE, BY PRODUCT (2020 V/S 2027) (%)
      • FIGURE 28     KNEE GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 29     EXTREMITIES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020) (%)
      • FIGURE 30     SPINE GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 31     FUSION GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 32     NON-FUSION GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 33     NON-FUSION GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 34     ARTIFICIAL DISCS GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 35     TRAUMA GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 36     ORTHOBIOLOGICS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 37     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE, BY SURGERY TYPE (2020 V/S 2027) (%)
      • FIGURE 38     OPEN SURGERY GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 39     MINIMALLY INVASIVE SURGERY GLOBAL MARKET SHARE, BY REGION (2020 V/S 2027) (%)
      • FIGURE 40     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE, BY END-USERS (2020 V/S 2027) (%)
      • FIGURE 41     ORTHOPAEDIC DEVICES GLOBAL MARKET REVENUE, BY REGION (2019-2027) ($MN), CAGR (%)
      • FIGURE 42     ORTHOPAEDIC DEVICES GLOBAL MARKET SHARE BY REGION AND MARKET REVENUE BY COUNTRY, (2020) (%) ($MN)
      • FIGURE 43     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET SHARE, BY PRODUCT (2020) (%), CAGR (%)
      • FIGURE 44     NORTH AMERICA EXTREMITIES MARKET SHARE, BY PRODUCT TYPE (2020) (%)
      • FIGURE 45     NORTH AMERICA SPINE MARKET SHARE, BY PRODUCT TYPE AND FUSION, NON-FUSION DEVICES MARKET SHARE BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 46     NORTH AMERICA ORTHOBIOLOGICS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 47     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET SHARE, BY SURGERY TYPE AND END-USERS (2020 V/S 2027) (%)
      • FIGURE 48     NORTH AMERICA ORTHOPAEDIC DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 49     U.S. ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 50     REST OF NORTH AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 51     EUROPE ORTHOPAEDIC DEVICES MARKET SHARE, BY PRODUCT (2020) (%), CAGR (%)
      • FIGURE 52     EUROPE EXTREMITIES MARKET SHARE, BY PRODUCT TYPE (2020) (%)
      • FIGURE 53     EUROPE SPINE MARKET SHARE, BY PRODUCT TYPE AND FUSION, NON-FUSION DEVICES MARKET SHARE BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 54     EUROPE ORTHOBIOLOGICS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 55     EUROPE ORTHOPAEDIC DEVICES MARKET SHARE, BY SURGERY TYPE AND END-USERS (2020 V/S 2027) (%)
      • FIGURE 56     EUROPE ORTHOPAEDIC DEVICES MARKET SHARE, BY COUNTRY, (2020 V/S 2027) (%)
      • FIGURE 57     GERMANY ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 58     FRANCE ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 59     U.K. ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 60     REST OF EUROPE ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 61     APAC ORTHOPAEDIC DEVICES MARKET SHARE, BY PRODUCT, (2020) (%), CAGR (%)
      • FIGURE 62     APAC EXTREMITIES MARKET SHARE, BY PRODUCT TYPE (2020) (%)
      • FIGURE 63     APAC SPINE MARKET SHARE, BY PRODUCT TYPE AND FUSION, NON-FUSION DEVICES MARKET SHARE BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 64     APAC ORTHOBIOLOGICS MARKET SHARE, BY PRODUCT TYPE, (2020 V/S 2027) (%)
      • FIGURE 65     APAC ORTHOPAEDIC DEVICES MARKET SHARE, BY SURGERY TYPE AND END-USERS (2020 V/S 2027) (%)
      • FIGURE 66     APAC ORTHOPAEDIC DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 67     JAPAN ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 68     INDIA ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 69     CHINA ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 70     REST OF APAC ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 71     ROW ORTHOPAEDIC DEVICES MARKET SHARE, BY PRODUCT (2020) (%), CAGR (%)
      • FIGURE 72     ROW EXTREMITIES MARKET SHARE, BY PRODUCT TYPE (2020) (%)
      • FIGURE 73     ROW SPINE MARKET SHARE, BY PRODUCT TYPE AND FUSION, NON-FUSION DEVICES MARKET SHARE BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 74     ROW ORTHOBIOLOGICS MARKET SHARE, BY PRODUCT TYPE (2020 V/S 2027) (%)
      • FIGURE 75     ROW ORTHOPAEDIC DEVICES MARKET SHARE, BY SURGERY TYPE AND END-USERS (2020 V/S 2027) (%)
      • FIGURE 76     ROW ORTHOPAEDIC DEVICES MARKET SHARE, BY COUNTRY (2020 V/S 2027) (%)
      • FIGURE 77     BRAZIL ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 78     REST OF LATIN AMERICA ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 79     MIDDLE EAST AND OTHERS ORTHOPAEDIC DEVICES MARKET REVENUE, BY PRODUCT, SURGERY TYPE AND END-USERS (2020 V/S 2027) ($MN)
      • FIGURE 80     KEY DEVELOPMENTS (2018 –2020)
      • FIGURE 81     SWOT: ARTHREX INC.
      • FIGURE 82     SWOT: B. BRAUN MELSUNGEN AG
      • FIGURE 83     SWOT: COLFAX CORPORATION (DJO, LLC)
      • FIGURE 84     SWOT: GLOBUS MEDICAL INC.
      • FIGURE 85     SWOT: JOHNSON & JOHNSON (DEPUY SYNTHES)
      • FIGURE 86     SWOT: MEDTRONIC PLC
      • FIGURE 87     SWOT: NUVASIVE INC.
      • FIGURE 88     SWOT: SMITH & NEPHEW PLC
      • FIGURE 89     SWOT: STRYKER CORPORATION
      • FIGURE 90     SWOT: ZIMMER BIOMET HOLDINGS INC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     Acuitive Technologies
      • 2     Acumed LLC
      • 3     Additive Orthopaedics, LLC
      • 4     Adler Ortho S.R.L
      • 5     AK Medical
      • 6     alloPlus GmbH
      • 7     Alphatec Holdings Inc
      • 8     Amplitude Surgical
      • 9     Anchor Orthopaedics XT Inc
      • 10     Aran Biomedical
      • 11     Arthrex Inc.
      • 12     Astura Medical
      • 13     Atlas Surgical Pvt
      • 14     Atro Medical, Inc.
      • 15     Auxein Medical
      • 16     B. Braun Melsungen AG
      • 17     Biomed Health Tech
      • 18     Biorez Inc.
      • 19     Bone Therapeutics
      • 20     Boneunion (Xiamen) Medical Devices Co. Ltd
      • 21     CarboFix Orthopaedic Ltd
      • 22     Carevature Medical Ltd.
      • 23     Carpenter Technology Corporation
      • 24     CartiHeal Ltd
      • 25     Centinel Spine, LLC
      • 26     Changzhou Meditech Trading Co., Ltd.
      • 27     Colfax Corporation
      • 28     Collagen Matrix, Inc.
      • 29     Conmed Corporation
      • 30     Consensus Orthopedics Inc.
      • 31     Corin group
      • 32     CurvaFix Inc.
      • 33     Dedienne Santé
      • 34     Eurosilicone SAS
      • 35     Exactech Inc
      • 36     Generex Biotechnology Corporation
      • 37     Guangzhou Sailong Additive Manufacturing Co., Ltd.
      • 38     Histogen Inc.
      • 39     Imen Ijaz Medical Engineering
      • 40     In2Bones Global, Inc
      • 41     Innovasis, Inc.
      • 42     Innovation Ortho Line Ltd
      • 43     Innovative Design Orthopaedics
      • 44     Integra Lifesciences
      • 45     Intrinsic Therapeutics Inc.
      • 46     Johnson & Johnson
      • 47     Kellogg's Research Labs
      • 48     LimaCorporate
      • 49     Maathys Medical
      • 50     MatOrtho Limited
      • 51     Medacta International SA
      • 52     Medartis AG
      • 53     MEDICALEX S A
      • 54     Medtronic Plc
      • 55     Merete
      • 56     Meril Life Sciences Pvt. Ltd
      • 57     Microport Scientific Corporation
      • 58     Neo Medical SA
      • 59     Neuro France implants
      • 60     Nexxt Spine, LLC
      • 61     NuVasive Inc.
      • 62     Olympus Corporation
      • 63     Ortho Consulting Group Holdings
      • 64     Ortho Regenerative Technologies Inc.
      • 65     Orthofix Medical Inc.
      • 66     Paonan Biotech Co., Ltd (BIOMECH)
      • 67     Premia Spine
      • 68     Regenexx Corporate
      • 69     REM Systems
      • 70     RTI Surgical
      • 71     SeaSpine Holdings Corporation
      • 72     Shakti Orthopaedic Industries (P) Ltd
      • 73     Showa Ika Kohgyo Co., Ltd.
      • 74     Siemens Healthineers
      • 75     Sigma Surgicals Pvt. Ltd.
      • 76     SIGNUS Medizintechnik GmbH
      • 77     Simplify Medical, Inc.
      • 78     Smith & Nephew Plc
      • 79     Spinal Elements Inc.
      • 80     Stryker Corporation
      • 81     Surgival International
      • 82     Synergy Disc Replacement Inc.
      • 83     TINAVI
      • 84     Tyber Medical, LLC,
      • 85     Ulrich Medical USA, Inc.
      • 86     Waldemar Link GmbH & Co. KG
      • 87     WishBone Medical
      • 88     Zimmer and Biomet Holdings Inc
      • 89     Z-Medical GmbH + Co. KG